ID   NCC-RbC-39
AC   CVCL_3047
SY   NCC-RbC-R39; R39
DR   CLO; CLO_0050128
DR   BioSample; SAMN01821704
DR   BioSample; SAMN03472394
DR   JCRB; JCRB1305
DR   JCRB; NIHS0511
DR   RCB; RCB2205
DR   Wikidata; Q54907619
RX   CelloPub=CLPUB00087;
CC   Population: Japanese.
CC   Doubling time: 64 hours (CelloPub=CLPUB00087).
CC   Discontinued: JCRB; NIHS0511; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001696.
ST   Source(s): JCRB=JCRB1305; RCB=RCB2205
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   CelloPub=CLPUB00087;
RA   Inomata M., Sasaki M.S., Hirota T., Itabashi M., Tsumuraga M.,
RA   Kaneko A., Hoshi A., Koyama Y., Saijo N.;
RT   "Establishment of a human retinoblastoma cell line: NCC-RbC-39.";
RL   Cancer J. 4:18-23(1991).
//